Global Cell-free DNA Mutation Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Cell-free DNA Mutation Diagnostics market size will reach USD 21560 million in 2031, growing at a CAGR of 14.6% over the analysis period.
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
This report is a detailed and comprehensive analysis for global Cell-free DNA Mutation Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell-free DNA Mutation Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell-free DNA Mutation Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell-free DNA Mutation Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell-free DNA Mutation Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell-free DNA Mutation Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-free DNA Mutation Diagnostics, with revenue, gross margin, and global market share of Cell-free DNA Mutation Diagnostics from 2020 to 2025.
Chapter 3, the Cell-free DNA Mutation Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell-free DNA Mutation Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free DNA Mutation Diagnostics.
Chapter 13, to describe Cell-free DNA Mutation Diagnostics research findings and conclusion.
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
This report is a detailed and comprehensive analysis for global Cell-free DNA Mutation Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell-free DNA Mutation Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell-free DNA Mutation Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell-free DNA Mutation Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell-free DNA Mutation Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Natera, Guardant, Freenome Holdings, GRAIL, Exact Sciences Corporation, Foundation Medicine, Biocept, Thermo Fisher Scientific, Roche Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell-free DNA Mutation Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Kits
- Instruments
- Services
- Hoispital
- Clinic
- Laboratories
- Others
- Illumina
- Natera
- Guardant
- Freenome Holdings
- GRAIL
- Exact Sciences Corporation
- Foundation Medicine
- Biocept
- Thermo Fisher Scientific
- Roche Diagnostics
- Agilent Technologies
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Myriad Genetics
- BillionToOne
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell-free DNA Mutation Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-free DNA Mutation Diagnostics, with revenue, gross margin, and global market share of Cell-free DNA Mutation Diagnostics from 2020 to 2025.
Chapter 3, the Cell-free DNA Mutation Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell-free DNA Mutation Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free DNA Mutation Diagnostics.
Chapter 13, to describe Cell-free DNA Mutation Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell-free DNA Mutation Diagnostics by Type
1.3.1 Overview: Global Cell-free DNA Mutation Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 Kits
1.3.4 Instruments
1.3.5 Services
1.4 Global Cell-free DNA Mutation Diagnostics Market by Application
1.4.1 Overview: Global Cell-free DNA Mutation Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hoispital
1.4.3 Clinic
1.4.4 Laboratories
1.4.5 Others
1.5 Global Cell-free DNA Mutation Diagnostics Market Size & Forecast
1.6 Global Cell-free DNA Mutation Diagnostics Market Size and Forecast by Region
1.6.1 Global Cell-free DNA Mutation Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Cell-free DNA Mutation Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Cell-free DNA Mutation Diagnostics Product and Solutions
2.1.4 Illumina Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Cell-free DNA Mutation Diagnostics Product and Solutions
2.2.4 Natera Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Natera Recent Developments and Future Plans
2.3 Guardant
2.3.1 Guardant Details
2.3.2 Guardant Major Business
2.3.3 Guardant Cell-free DNA Mutation Diagnostics Product and Solutions
2.3.4 Guardant Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Guardant Recent Developments and Future Plans
2.4 Freenome Holdings
2.4.1 Freenome Holdings Details
2.4.2 Freenome Holdings Major Business
2.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
2.4.4 Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Freenome Holdings Recent Developments and Future Plans
2.5 GRAIL
2.5.1 GRAIL Details
2.5.2 GRAIL Major Business
2.5.3 GRAIL Cell-free DNA Mutation Diagnostics Product and Solutions
2.5.4 GRAIL Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 GRAIL Recent Developments and Future Plans
2.6 Exact Sciences Corporation
2.6.1 Exact Sciences Corporation Details
2.6.2 Exact Sciences Corporation Major Business
2.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product and Solutions
2.6.4 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Exact Sciences Corporation Recent Developments and Future Plans
2.7 Foundation Medicine
2.7.1 Foundation Medicine Details
2.7.2 Foundation Medicine Major Business
2.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Product and Solutions
2.7.4 Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Foundation Medicine Recent Developments and Future Plans
2.8 Biocept
2.8.1 Biocept Details
2.8.2 Biocept Major Business
2.8.3 Biocept Cell-free DNA Mutation Diagnostics Product and Solutions
2.8.4 Biocept Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Biocept Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product and Solutions
2.9.4 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.10 Roche Diagnostics
2.10.1 Roche Diagnostics Details
2.10.2 Roche Diagnostics Major Business
2.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product and Solutions
2.10.4 Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Roche Diagnostics Recent Developments and Future Plans
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business
2.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Product and Solutions
2.11.4 Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Agilent Technologies Recent Developments and Future Plans
2.12 Quest Diagnostics Incorporated
2.12.1 Quest Diagnostics Incorporated Details
2.12.2 Quest Diagnostics Incorporated Major Business
2.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product and Solutions
2.12.4 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
2.13 Laboratory Corporation of America Holdings
2.13.1 Laboratory Corporation of America Holdings Details
2.13.2 Laboratory Corporation of America Holdings Major Business
2.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
2.13.4 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.14 Myriad Genetics
2.14.1 Myriad Genetics Details
2.14.2 Myriad Genetics Major Business
2.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Product and Solutions
2.14.4 Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Myriad Genetics Recent Developments and Future Plans
2.15 BillionToOne
2.15.1 BillionToOne Details
2.15.2 BillionToOne Major Business
2.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Product and Solutions
2.15.4 BillionToOne Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 BillionToOne Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell-free DNA Mutation Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Cell-free DNA Mutation Diagnostics by Company Revenue
3.2.2 Top 3 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
3.2.3 Top 6 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
3.3 Cell-free DNA Mutation Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Cell-free DNA Mutation Diagnostics Market: Region Footprint
3.3.2 Cell-free DNA Mutation Diagnostics Market: Company Product Type Footprint
3.3.3 Cell-free DNA Mutation Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell-free DNA Mutation Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Cell-free DNA Mutation Diagnostics Market Size by Application (2020-2031)
6.3 North America Cell-free DNA Mutation Diagnostics Market Size by Country
6.3.1 North America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Cell-free DNA Mutation Diagnostics Market Size by Country
7.3.1 Europe Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region
8.3.1 Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Cell-free DNA Mutation Diagnostics Market Size by Country
9.3.1 South America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country
10.3.1 Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Cell-free DNA Mutation Diagnostics Market Drivers
11.2 Cell-free DNA Mutation Diagnostics Market Restraints
11.3 Cell-free DNA Mutation Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell-free DNA Mutation Diagnostics Industry Chain
12.2 Cell-free DNA Mutation Diagnostics Upstream Analysis
12.3 Cell-free DNA Mutation Diagnostics Midstream Analysis
12.4 Cell-free DNA Mutation Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell-free DNA Mutation Diagnostics by Type
1.3.1 Overview: Global Cell-free DNA Mutation Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 Kits
1.3.4 Instruments
1.3.5 Services
1.4 Global Cell-free DNA Mutation Diagnostics Market by Application
1.4.1 Overview: Global Cell-free DNA Mutation Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hoispital
1.4.3 Clinic
1.4.4 Laboratories
1.4.5 Others
1.5 Global Cell-free DNA Mutation Diagnostics Market Size & Forecast
1.6 Global Cell-free DNA Mutation Diagnostics Market Size and Forecast by Region
1.6.1 Global Cell-free DNA Mutation Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Cell-free DNA Mutation Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Cell-free DNA Mutation Diagnostics Product and Solutions
2.1.4 Illumina Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Cell-free DNA Mutation Diagnostics Product and Solutions
2.2.4 Natera Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Natera Recent Developments and Future Plans
2.3 Guardant
2.3.1 Guardant Details
2.3.2 Guardant Major Business
2.3.3 Guardant Cell-free DNA Mutation Diagnostics Product and Solutions
2.3.4 Guardant Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Guardant Recent Developments and Future Plans
2.4 Freenome Holdings
2.4.1 Freenome Holdings Details
2.4.2 Freenome Holdings Major Business
2.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
2.4.4 Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Freenome Holdings Recent Developments and Future Plans
2.5 GRAIL
2.5.1 GRAIL Details
2.5.2 GRAIL Major Business
2.5.3 GRAIL Cell-free DNA Mutation Diagnostics Product and Solutions
2.5.4 GRAIL Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 GRAIL Recent Developments and Future Plans
2.6 Exact Sciences Corporation
2.6.1 Exact Sciences Corporation Details
2.6.2 Exact Sciences Corporation Major Business
2.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product and Solutions
2.6.4 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Exact Sciences Corporation Recent Developments and Future Plans
2.7 Foundation Medicine
2.7.1 Foundation Medicine Details
2.7.2 Foundation Medicine Major Business
2.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Product and Solutions
2.7.4 Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Foundation Medicine Recent Developments and Future Plans
2.8 Biocept
2.8.1 Biocept Details
2.8.2 Biocept Major Business
2.8.3 Biocept Cell-free DNA Mutation Diagnostics Product and Solutions
2.8.4 Biocept Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Biocept Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product and Solutions
2.9.4 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.10 Roche Diagnostics
2.10.1 Roche Diagnostics Details
2.10.2 Roche Diagnostics Major Business
2.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product and Solutions
2.10.4 Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Roche Diagnostics Recent Developments and Future Plans
2.11 Agilent Technologies
2.11.1 Agilent Technologies Details
2.11.2 Agilent Technologies Major Business
2.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Product and Solutions
2.11.4 Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Agilent Technologies Recent Developments and Future Plans
2.12 Quest Diagnostics Incorporated
2.12.1 Quest Diagnostics Incorporated Details
2.12.2 Quest Diagnostics Incorporated Major Business
2.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product and Solutions
2.12.4 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
2.13 Laboratory Corporation of America Holdings
2.13.1 Laboratory Corporation of America Holdings Details
2.13.2 Laboratory Corporation of America Holdings Major Business
2.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
2.13.4 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.14 Myriad Genetics
2.14.1 Myriad Genetics Details
2.14.2 Myriad Genetics Major Business
2.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Product and Solutions
2.14.4 Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Myriad Genetics Recent Developments and Future Plans
2.15 BillionToOne
2.15.1 BillionToOne Details
2.15.2 BillionToOne Major Business
2.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Product and Solutions
2.15.4 BillionToOne Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 BillionToOne Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell-free DNA Mutation Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Cell-free DNA Mutation Diagnostics by Company Revenue
3.2.2 Top 3 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
3.2.3 Top 6 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
3.3 Cell-free DNA Mutation Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Cell-free DNA Mutation Diagnostics Market: Region Footprint
3.3.2 Cell-free DNA Mutation Diagnostics Market: Company Product Type Footprint
3.3.3 Cell-free DNA Mutation Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell-free DNA Mutation Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Cell-free DNA Mutation Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Cell-free DNA Mutation Diagnostics Market Size by Application (2020-2031)
6.3 North America Cell-free DNA Mutation Diagnostics Market Size by Country
6.3.1 North America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Cell-free DNA Mutation Diagnostics Market Size by Country
7.3.1 Europe Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region
8.3.1 Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Cell-free DNA Mutation Diagnostics Market Size by Country
9.3.1 South America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country
10.3.1 Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Cell-free DNA Mutation Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Cell-free DNA Mutation Diagnostics Market Drivers
11.2 Cell-free DNA Mutation Diagnostics Market Restraints
11.3 Cell-free DNA Mutation Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell-free DNA Mutation Diagnostics Industry Chain
12.2 Cell-free DNA Mutation Diagnostics Upstream Analysis
12.3 Cell-free DNA Mutation Diagnostics Midstream Analysis
12.4 Cell-free DNA Mutation Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell-free DNA Mutation Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cell-free DNA Mutation Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Cell-free DNA Mutation Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Cell-free DNA Mutation Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Cell-free DNA Mutation Diagnostics Product and Solutions
Table 8. Illumina Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Illumina Recent Developments and Future Plans
Table 10. Natera Company Information, Head Office, and Major Competitors
Table 11. Natera Major Business
Table 12. Natera Cell-free DNA Mutation Diagnostics Product and Solutions
Table 13. Natera Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Natera Recent Developments and Future Plans
Table 15. Guardant Company Information, Head Office, and Major Competitors
Table 16. Guardant Major Business
Table 17. Guardant Cell-free DNA Mutation Diagnostics Product and Solutions
Table 18. Guardant Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Freenome Holdings Company Information, Head Office, and Major Competitors
Table 20. Freenome Holdings Major Business
Table 21. Freenome Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
Table 22. Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Freenome Holdings Recent Developments and Future Plans
Table 24. GRAIL Company Information, Head Office, and Major Competitors
Table 25. GRAIL Major Business
Table 26. GRAIL Cell-free DNA Mutation Diagnostics Product and Solutions
Table 27. GRAIL Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. GRAIL Recent Developments and Future Plans
Table 29. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 30. Exact Sciences Corporation Major Business
Table 31. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product and Solutions
Table 32. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Exact Sciences Corporation Recent Developments and Future Plans
Table 34. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 35. Foundation Medicine Major Business
Table 36. Foundation Medicine Cell-free DNA Mutation Diagnostics Product and Solutions
Table 37. Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Foundation Medicine Recent Developments and Future Plans
Table 39. Biocept Company Information, Head Office, and Major Competitors
Table 40. Biocept Major Business
Table 41. Biocept Cell-free DNA Mutation Diagnostics Product and Solutions
Table 42. Biocept Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Biocept Recent Developments and Future Plans
Table 44. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 45. Thermo Fisher Scientific Major Business
Table 46. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product and Solutions
Table 47. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Thermo Fisher Scientific Recent Developments and Future Plans
Table 49. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Roche Diagnostics Major Business
Table 51. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product and Solutions
Table 52. Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Roche Diagnostics Recent Developments and Future Plans
Table 54. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 55. Agilent Technologies Major Business
Table 56. Agilent Technologies Cell-free DNA Mutation Diagnostics Product and Solutions
Table 57. Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Agilent Technologies Recent Developments and Future Plans
Table 59. Quest Diagnostics Incorporated Company Information, Head Office, and Major Competitors
Table 60. Quest Diagnostics Incorporated Major Business
Table 61. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product and Solutions
Table 62. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Quest Diagnostics Incorporated Recent Developments and Future Plans
Table 64. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 65. Laboratory Corporation of America Holdings Major Business
Table 66. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
Table 67. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 69. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 70. Myriad Genetics Major Business
Table 71. Myriad Genetics Cell-free DNA Mutation Diagnostics Product and Solutions
Table 72. Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Myriad Genetics Recent Developments and Future Plans
Table 74. BillionToOne Company Information, Head Office, and Major Competitors
Table 75. BillionToOne Major Business
Table 76. BillionToOne Cell-free DNA Mutation Diagnostics Product and Solutions
Table 77. BillionToOne Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. BillionToOne Recent Developments and Future Plans
Table 79. Global Cell-free DNA Mutation Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 80. Global Cell-free DNA Mutation Diagnostics Revenue Share by Players (2020-2025)
Table 81. Breakdown of Cell-free DNA Mutation Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Cell-free DNA Mutation Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 83. Head Office of Key Cell-free DNA Mutation Diagnostics Players
Table 84. Cell-free DNA Mutation Diagnostics Market: Company Product Type Footprint
Table 85. Cell-free DNA Mutation Diagnostics Market: Company Product Application Footprint
Table 86. Cell-free DNA Mutation Diagnostics New Market Entrants and Barriers to Market Entry
Table 87. Cell-free DNA Mutation Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Cell-free DNA Mutation Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 89. Global Cell-free DNA Mutation Diagnostics Consumption Value Share by Type (2020-2025)
Table 90. Global Cell-free DNA Mutation Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 91. Global Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025)
Table 92. Global Cell-free DNA Mutation Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 93. North America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 94. North America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 95. North America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 96. North America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 97. North America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 100. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 101. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 102. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 103. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 104. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 105. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 106. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 107. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 110. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 111. South America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 112. South America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 113. South America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 114. South America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 115. South America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 116. South America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 118. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 119. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 120. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 121. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 122. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Global Key Players of Cell-free DNA Mutation Diagnostics Upstream (Raw Materials)
Table 124. Global Cell-free DNA Mutation Diagnostics Typical Customers
Table 1. Global Cell-free DNA Mutation Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cell-free DNA Mutation Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Cell-free DNA Mutation Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Cell-free DNA Mutation Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Cell-free DNA Mutation Diagnostics Product and Solutions
Table 8. Illumina Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Illumina Recent Developments and Future Plans
Table 10. Natera Company Information, Head Office, and Major Competitors
Table 11. Natera Major Business
Table 12. Natera Cell-free DNA Mutation Diagnostics Product and Solutions
Table 13. Natera Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Natera Recent Developments and Future Plans
Table 15. Guardant Company Information, Head Office, and Major Competitors
Table 16. Guardant Major Business
Table 17. Guardant Cell-free DNA Mutation Diagnostics Product and Solutions
Table 18. Guardant Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Freenome Holdings Company Information, Head Office, and Major Competitors
Table 20. Freenome Holdings Major Business
Table 21. Freenome Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
Table 22. Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Freenome Holdings Recent Developments and Future Plans
Table 24. GRAIL Company Information, Head Office, and Major Competitors
Table 25. GRAIL Major Business
Table 26. GRAIL Cell-free DNA Mutation Diagnostics Product and Solutions
Table 27. GRAIL Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. GRAIL Recent Developments and Future Plans
Table 29. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 30. Exact Sciences Corporation Major Business
Table 31. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product and Solutions
Table 32. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Exact Sciences Corporation Recent Developments and Future Plans
Table 34. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 35. Foundation Medicine Major Business
Table 36. Foundation Medicine Cell-free DNA Mutation Diagnostics Product and Solutions
Table 37. Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Foundation Medicine Recent Developments and Future Plans
Table 39. Biocept Company Information, Head Office, and Major Competitors
Table 40. Biocept Major Business
Table 41. Biocept Cell-free DNA Mutation Diagnostics Product and Solutions
Table 42. Biocept Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Biocept Recent Developments and Future Plans
Table 44. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 45. Thermo Fisher Scientific Major Business
Table 46. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product and Solutions
Table 47. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Thermo Fisher Scientific Recent Developments and Future Plans
Table 49. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Roche Diagnostics Major Business
Table 51. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product and Solutions
Table 52. Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Roche Diagnostics Recent Developments and Future Plans
Table 54. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 55. Agilent Technologies Major Business
Table 56. Agilent Technologies Cell-free DNA Mutation Diagnostics Product and Solutions
Table 57. Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Agilent Technologies Recent Developments and Future Plans
Table 59. Quest Diagnostics Incorporated Company Information, Head Office, and Major Competitors
Table 60. Quest Diagnostics Incorporated Major Business
Table 61. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product and Solutions
Table 62. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Quest Diagnostics Incorporated Recent Developments and Future Plans
Table 64. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 65. Laboratory Corporation of America Holdings Major Business
Table 66. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product and Solutions
Table 67. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 69. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 70. Myriad Genetics Major Business
Table 71. Myriad Genetics Cell-free DNA Mutation Diagnostics Product and Solutions
Table 72. Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Myriad Genetics Recent Developments and Future Plans
Table 74. BillionToOne Company Information, Head Office, and Major Competitors
Table 75. BillionToOne Major Business
Table 76. BillionToOne Cell-free DNA Mutation Diagnostics Product and Solutions
Table 77. BillionToOne Cell-free DNA Mutation Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. BillionToOne Recent Developments and Future Plans
Table 79. Global Cell-free DNA Mutation Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 80. Global Cell-free DNA Mutation Diagnostics Revenue Share by Players (2020-2025)
Table 81. Breakdown of Cell-free DNA Mutation Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Cell-free DNA Mutation Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 83. Head Office of Key Cell-free DNA Mutation Diagnostics Players
Table 84. Cell-free DNA Mutation Diagnostics Market: Company Product Type Footprint
Table 85. Cell-free DNA Mutation Diagnostics Market: Company Product Application Footprint
Table 86. Cell-free DNA Mutation Diagnostics New Market Entrants and Barriers to Market Entry
Table 87. Cell-free DNA Mutation Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Cell-free DNA Mutation Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 89. Global Cell-free DNA Mutation Diagnostics Consumption Value Share by Type (2020-2025)
Table 90. Global Cell-free DNA Mutation Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 91. Global Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025)
Table 92. Global Cell-free DNA Mutation Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 93. North America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 94. North America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 95. North America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 96. North America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 97. North America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 100. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 101. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 102. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 103. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 104. Europe Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 105. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 106. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 107. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 108. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 109. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 110. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 111. South America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 112. South America Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 113. South America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 114. South America Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 115. South America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 116. South America Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 118. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 119. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 120. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 121. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 122. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Global Key Players of Cell-free DNA Mutation Diagnostics Upstream (Raw Materials)
Table 124. Global Cell-free DNA Mutation Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Cell-free DNA Mutation Diagnostics Picture
Figure 2. Global Cell-free DNA Mutation Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. Kits
Figure 5. Instruments
Figure 6. Services
Figure 7. Global Cell-free DNA Mutation Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application in 2024
Figure 9. Hoispital Picture
Figure 10. Clinic Picture
Figure 11. Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Cell-free DNA Mutation Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Cell-free DNA Mutation Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Cell-free DNA Mutation Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Region in 2024
Figure 18. North America Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Cell-free DNA Mutation Diagnostics Revenue Share by Players in 2024
Figure 25. Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Cell-free DNA Mutation Diagnostics by Player Revenue in 2024
Figure 27. Top 3 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
Figure 28. Top 6 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
Figure 29. Global Cell-free DNA Mutation Diagnostics Consumption Value Share by Type (2020-2025)
Figure 30. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Type (2026-2031)
Figure 31. Global Cell-free DNA Mutation Diagnostics Consumption Value Share by Application (2020-2025)
Figure 32. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Application (2026-2031)
Figure 33. North America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. France Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 50. China Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. India Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 67. Cell-free DNA Mutation Diagnostics Market Drivers
Figure 68. Cell-free DNA Mutation Diagnostics Market Restraints
Figure 69. Cell-free DNA Mutation Diagnostics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Cell-free DNA Mutation Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Cell-free DNA Mutation Diagnostics Picture
Figure 2. Global Cell-free DNA Mutation Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. Kits
Figure 5. Instruments
Figure 6. Services
Figure 7. Global Cell-free DNA Mutation Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application in 2024
Figure 9. Hoispital Picture
Figure 10. Clinic Picture
Figure 11. Laboratories Picture
Figure 12. Others Picture
Figure 13. Global Cell-free DNA Mutation Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Cell-free DNA Mutation Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Cell-free DNA Mutation Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Region in 2024
Figure 18. North America Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Cell-free DNA Mutation Diagnostics Revenue Share by Players in 2024
Figure 25. Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Cell-free DNA Mutation Diagnostics by Player Revenue in 2024
Figure 27. Top 3 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
Figure 28. Top 6 Cell-free DNA Mutation Diagnostics Players Market Share in 2024
Figure 29. Global Cell-free DNA Mutation Diagnostics Consumption Value Share by Type (2020-2025)
Figure 30. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Type (2026-2031)
Figure 31. Global Cell-free DNA Mutation Diagnostics Consumption Value Share by Application (2020-2025)
Figure 32. Global Cell-free DNA Mutation Diagnostics Market Share Forecast by Application (2026-2031)
Figure 33. North America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. France Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 50. China Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. India Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Cell-free DNA Mutation Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Cell-free DNA Mutation Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 67. Cell-free DNA Mutation Diagnostics Market Drivers
Figure 68. Cell-free DNA Mutation Diagnostics Market Restraints
Figure 69. Cell-free DNA Mutation Diagnostics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Cell-free DNA Mutation Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
